Related Experiment Video

Updated: Jan 1, 2026

RNA Interference in Aquatic Beetles as a Powerful Tool for Manipulating Gene Expression at Specific Developmental Time Points
08:55

RNA Interference in Aquatic Beetles as a Powerful Tool for Manipulating Gene Expression at Specific Developmental Time Points

Published on: May 29, 2020

8.1K

Editorial focus: understanding off-target effects as the key to successful RNAi therapy

Rafal Bartoszewski1, Aleksander F Sikorski2

  • 11Department of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.

Cellular & Molecular Biology Letters
|December 24, 2019
PubMed

Insights

RNA interference (RNAi) therapy is advancing, but assessing drug safety early is crucial. Early in vitro profiling of RNAi drug candidates can prevent delays and ensure patient safety.

Area of Science:

  • Biotechnology
  • Pharmacology
  • Molecular Biology

Background:

  • The first RNA interference (RNAi) drug, ONPATTRO (patisiran), marks a significant milestone in RNAi therapeutics.
  • Advancements in drug design and delivery are accelerating the development of novel RNAi treatments.
  • However, potential off-target effects of RNAi drugs necessitate robust safety profiling.

Purpose of the Study:

  • To provide a concise overview of RNA interference (RNAi) therapy.
  • To emphasize the importance of in vitro pharmacological profiling for RNAi drug candidates.
  • To discuss the translation of basic research into early safety assessments for RNAi therapeutics.

Main Methods:

  • Review of current RNAi therapy landscape.
  • Discussion of in vitro pharmacological profiling strategies.
  • Analysis of translating basic research findings into safety assessments.

Main Results:

  • The RNAi field is at a critical juncture with the advent of approved therapies.
  • In vitro profiling is essential for identifying and mitigating off-target activities.
  • Early safety evaluation can streamline the development of new RNAi drugs.

Conclusions:

  • Integrating early safety assessments is vital for the continued progress of RNAi therapeutics.
  • Translating basic research into practical safety profiling methods is key.
  • Proactive identification of off-target effects will accelerate the delivery of safe and effective RNAi treatments.
Keywords:
Off-target effectsRNAi drug candidatesRNAi therapymicroRNAsncRNAssiRNAs

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Larval RNA Interference in the Red Flour Beetle, Tribolium castaneum11:00

Larval RNA Interference in the Red Flour Beetle, Tribolium castaneum

Published on: October 13, 2014

16.7K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.9K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.7K